x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The Lancet Respiratory Medicine in conversation with

The Lancet Group

Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COVID outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.

health & fitness medicine

All Episodes

10:50

Finn McQuaid and Matthew Saunders on Tuberculosis and...

The Lancet Respiratory Medicine in conversation with ·

2025/10/30

Dr Finn McQuaid and Dr Matthew Saunders join Arianna Colosio to discuss an analytical framework to describe potential causal relationships between climate change and tuberculosis. Click here to read the full article Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

en

9:26

Toby Maher on ENV-101 in patients with idiopathic...

The Lancet Respiratory Medicine in conversation with ·

2025/09/28

Toby Maher joins us to discuss results of a randomised, double-blind, placebo-controlled, proof-of-concept trial of ENV-101, an oral inhibitor of the hedgehog signalling pathway, in patients with idiopathic pulmonary fibrosis. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00239-5/fulltext?dgcid=buzzsprout_icw_podcast_September_25_lanres Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/t...

en

22:43

Guy Brusselle and Celeste Porsbjerg on...

The Lancet Respiratory Medicine in conversation with ·

2025/09/28

Professors Guy Brusselle and Celeste Porsbjerg join us to discuss their recent Series papers on asthma, which will be featured in a cross journal project with The Lancet, published to coincide with a Lancet journal session on asthma at ERS in Amsterdam. The Series aims to provide an overview of recent research advances related to asthma; to provide new insights into the genetics, prevention and risk factors for asthma; review advances arising as a result of the use of monoclonal antibod...

en

10:31

Joan Soriano on Global Epidemiology of Respiratory...

The Lancet Respiratory Medicine in conversation with ·

2025/07/17

Diana Stanley, Deputy Editor at The Lancet Respiratory Medicine, is joined by Dr Joan Soriano to discuss a new series on the global epidemiology of respiratory disease, exploring the diagnostic challenges, global trends, and future directions for prevention. Read the full Series: https://www.thelancet.com/series-do/global-epidemiology-chronic-respiratory-disease?dgcid=buzzsprout_icw_podcast_lanrescrd25_lanres Continue this conversation on social! Follow us today at... https://thelancet.bsky.s...

en

18:45

Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q...

The Lancet Respiratory Medicine in conversation with ·

2025/07/16

Carole Mitnick & Lorenzo Guglielmetti join Ari Colosio, deputy editor of The Lancet Respiratory Medicine, to discuss the ENDTB-Q trial to evaluate the efficacy and safety of a drug regiment to treat TB in individuals with pre-extensively drug-resistant tuberculosis. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanres Continue this conversation on social! Follow us today at... https://thelanc...

en

14:54

Lorenzo Guglielmetti parla del trial clinico ENDTB-Q...

The Lancet Respiratory Medicine in conversation with ·

2025/07/16

This episode is in Italian. For the English version, please see the main feed. Lorenzo Guglielmetti sul trial clinico ENDTB-Q per valutare l’efficacia e la sicurezza di un regime di farmaci per curare la tubercolosi in individui con tubercolosi pre-estesa farmaco-resistente. Leggi l'articolo completo: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanres Continue this conversation on social! Follow us today at... https:...

en

12:10

Laura Garriga-Grimau on bronchiectasis in children...

The Lancet Respiratory Medicine in conversation with ·

2025/07/02

Deputy editor Ari Colosio speaks with Dr. Laura Garriga-Grimau of the Val d’Hebron Hospital, Autonomous University of Barcelona. Dr. Garriga-Grimau discusses the first multi-country cohort study to describe the clinical features and standards of care for children and young people with bronchiectasis, drawing on data from the International Pediatric Bronchiectasis Registry. Together, they examine key findings on regional differences in diagnosis, co-morbidities, clinical severity, and treatmen...

en

11:51

Marcus J Schultz and Prashant Nasa on defining and...

The Lancet Respiratory Medicine in conversation with ·

2025/06/04

Bianca Brandon is joined by Professor Marcus Schultz and Dr Prashant Nasa to discuss their recent Position Paper reporting insights from an international Delphi expert panel on defining and subphenotyping ARDS. The findings underscore the need to refine the ARDS definition to better address heterogeneity of the condition and improve diagnostic precision, with use of subphenotyping where appropriate. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)0011...

en

13:33

Hjalmar Bouma on sepsis in patients who are...

The Lancet Respiratory Medicine in conversation with ·

2025/05/20

Bianca Brandon, Senior Editor at The Lancet Respiratory Medicine, is joined by Professor Hjalmar Bouma to discuss a new review on sepsis in immunocompromised patients, exploring the diagnostic challenges, complexities of immune status, and future directions for targeted therapies. The episode also analyses the increased vulnerability of specific patient groups, the importance of biomarker-driven personalised medicine, and the need for improved representation of immunosuppressed patients in cl...

en

11:47

Simon Wolf on pulmonary embolism in children and...

The Lancet Respiratory Medicine in conversation with ·

2025/04/07

Deputy Editor of The Lancet Respiratory Medicine Ari Colosio discusses the critical findings of a new epidemiological study on pulmonary embolism in children and adolescents with Simon Wolf from the University Hospital of Zurich. This episode delves into the prevalence, risk factors, and clinical implications of this rare but serious condition, highlighting the need for increased awareness and further research. Read the full article: https://www.thelancet.com/journals/lanres/articl...

en

14:53

Sandeep Sahay and Franck Rahaghi on future treatment...

The Lancet Respiratory Medicine in conversation with ·

2025/02/19

Dr Sandeep Sahay and Professor Franck Rahaghi discuss their Personal View on future treatment paradigms in pulmonary arterial hypertension. Read the full paper, Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients, here: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00425-9/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com...

en

10:26

Sergio Harari on the treatment of...

The Lancet Respiratory Medicine in conversation with ·

2024/10/25

Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

en

10:40

Sergio Harari sul trattamento della...

The Lancet Respiratory Medicine in conversation with ·

2024/10/25

Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM).Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

en

12:06

Robert Kullberg on empirical antibiotics for Sepsis

The Lancet Respiratory Medicine in conversation with ·

2024/10/11

Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

en

19:07

Heather Zar on early-life RSV disease and long-term...

The Lancet Respiratory Medicine in conversation with ·

2024/09/09

Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet.You can read the Series of papers at:https://www.thelancet.com/series/respiratory-syncytial-virus?dgcid=buzzsprout_icw_podcast_genericContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebo...

en

10:25

Margaux Mesle on lives saved by COVID-19 vaccination

The Lancet Respiratory Medicine in conversation with ·

2024/08/07

Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 2023 and public health implications.Read the full article:https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00179-6?dgcid=buzzsprout_icw_podcast_generic_lanresContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps:...

en

11:04

James Hull on protecting the respiratory health of...

The Lancet Respiratory Medicine in conversation with ·

2024/07/25

Professor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paralympics.Read the full article:https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00183-8?dgcid=buzzsprout_icw_podcast_generic_lanresContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-l...

en

6:17

Eric Lim on treatments for pleural mesothelioma

The Lancet Respiratory Medicine in conversation with ·

2024/05/10

Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

en

9:49

Anne Chang on the burden of chronic respiratory...

The Lancet Respiratory Medicine in conversation with ·

2024/04/24

en

10:23

Daniel Steinfort and Shankar Siva on radiotherapy...

The Lancet Respiratory Medicine in conversation with ·

2024/03/12

en

57 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown